Quantcast

Latest Octreotide Stories

2011-11-30 10:45:17

Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome.

2011-06-06 05:00:00

NEW YORK and JERUSALEM, June 6, 2011 /PRNewswire/ -- Chiasma, Inc., a privately held biopharma company, presented pharmacology results from clinical studies at the 12th International Pituitary Congress showing that Octreolin, a proprietary investigational new oral formulation of octreotide, demonstrated a consistent pharmacokinetic (PK) profile similar to that of subcutaneously injected octreotide acetate.

2011-04-05 06:00:00

PITTSBURGH, April 5, 2011 /PRNewswire/ -- Mylan Inc.

2011-01-31 13:58:40

Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually.

2010-10-12 18:11:50

The results of a large Phase-III clinical trial have shown that the drug everolimus delays tumor progression in patients with a hard-to-treat group of rare cancers that affect particular hormone-producing cells.


Word of the Day
onomatope
  • An imitative word; an onomatopoetic word.
The word 'onomatope' is a back-formation from 'onomatopoeia'.
Related